Multifactorial Effects of Vildagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Strozik, Agnieszka
Steposz, Arkadiusz
Okopien, Boguslaw
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2624-PO
引用
收藏
页码：A668 / A668
页数：1
相关论文
共 50 条
  • [1] Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Strozik, Agnieszka
    Steposz, Arkadiusz
    Basiak, Marcin
    Drozdz, Magdalena
    Okopien, Boguslaw
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 24 - 31
  • [2] Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Agnieszka Strózik
    Arkadiusz Stęposz
    Marcin Basiak
    Magdalena Drożdż
    Bogusław Okopień
    Pharmacological Reports, 2015, 67 : 24 - 31
  • [3] The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Kim, Gyuri
    Oh, Sewon
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    Lee, Moon-Kyu
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1179 - 1186
  • [4] Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus
    Guarino, Elisa
    Nigi, Laura
    Patti, Aurora
    Fondelli, Cecilia
    Dotta, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) : 1377 - 1384
  • [5] Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
    Kothny, W.
    Foley, J.
    Kozlovski, P.
    Shao, Q.
    Gallwitz, B.
    Lukashevich, V.
    DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 252 - 257
  • [6] Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
    Raz, Itamar
    Chen, Yu
    Wu, Mei
    Hussain, Shehla
    Kaufman, Keith D.
    Amatruda, John M.
    Langdon, Ronald B.
    Stein, Peter P.
    Alba, Maria
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 537 - 550
  • [7] The Combination Therapy With Metformin and Vildagliptin Decreases Lymphocytes Count in patients With Type 2 Diabetes Mellitus
    Zografou, Ioanna
    Sampanis, Christos
    Papageorgiou, Athanasios
    Nikolaidou, Barbara
    Doukelis, Panagiotis
    Papadopoulou, Despina
    Doumas, Michael
    Douma, Stella
    DIABETES, 2012, 61 : A600 - A600
  • [8] Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
    Tasci, Ilker
    Naharci, Mehmet Ilkin
    Bozoglu, Ergun
    Safer, Umut
    Aydogdu, Aydogan
    Yilmaz, Basak Filiz
    Yilmaz, Gulay
    Doruk, Huseyin
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2013, 13 (03) : 256 - 263
  • [9] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
  • [10] Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
    Pan, C.
    Xing, X.
    Han, P.
    Zheng, S.
    Ma, J.
    Liu, J.
    Lv, X.
    Lu, J.
    Bader, G.
    DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 737 - 744
12345